The pathology of lower grade isocitrate dehydrogenase (IDH) wildtype astrocytoma is difficult to interpret, because IDH wildtype diffuse or anaplastic astrocytomas (WHO grade II and III, respectively) may have clinical courses similar to glioblastoma (WHO grade IV)27,28. This evidence concerns the gene IDH1 and anaplastic astrocytoma.